Logo image of DTEA.CA

DAVIDSTEA INC (DTEA.CA) Stock Fundamental Analysis

TSX-V:DTEA - TSX Venture Exchange - CA2386611024 - Common Stock - Currency: CAD

1  -0.05 (-4.76%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DTEA. DTEA was compared to 16 industry peers in the Specialty Retail industry. DTEA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DTEA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year DTEA has reported negative net income.
DTEA had a positive operating cash flow in the past year.
DTEA had negative earnings in 4 of the past 5 years.
In multiple years DTEA reported negative operating cash flow during the last 5 years.
DTEA.CA Yearly Net Income VS EBIT VS OCF VS FCFDTEA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

1.2 Ratios

DTEA has a worse Return On Assets (-6.75%) than 75.00% of its industry peers.
DTEA's Return On Equity of -17.46% is on the low side compared to the rest of the industry. DTEA is outperformed by 68.75% of its industry peers.
Industry RankSector Rank
ROA -6.75%
ROE -17.46%
ROIC N/A
ROA(3y)-20.71%
ROA(5y)-6.31%
ROE(3y)-41.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DTEA.CA Yearly ROA, ROE, ROICDTEA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100

1.3 Margins

DTEA has a better Gross Margin (47.79%) than 75.00% of its industry peers.
In the last couple of years the Gross Margin of DTEA has declined.
DTEA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.52%
GM growth 5Y-2.86%
DTEA.CA Yearly Profit, Operating, Gross MarginsDTEA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

5

2. Health

2.1 Basic Checks

DTEA does not have a ROIC to compare to the WACC, probably because it is not profitable.
DTEA has more shares outstanding than it did 1 year ago.
DTEA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DTEA has a worse debt to assets ratio.
DTEA.CA Yearly Shares OutstandingDTEA.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
DTEA.CA Yearly Total Debt VS Total AssetsDTEA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

DTEA has an Altman-Z score of -1.10. This is a bad value and indicates that DTEA is not financially healthy and even has some risk of bankruptcy.
DTEA has a worse Altman-Z score (-1.10) than 81.25% of its industry peers.
DTEA has a debt to FCF ratio of 1.88. This is a very positive value and a sign of high solvency as it would only need 1.88 years to pay back of all of its debts.
The Debt to FCF ratio of DTEA (1.88) is better than 81.25% of its industry peers.
DTEA has a Debt/Equity ratio of 0.53. This is a neutral value indicating DTEA is somewhat dependend on debt financing.
The Debt to Equity ratio of DTEA (0.53) is better than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 1.88
Altman-Z -1.1
ROIC/WACCN/A
WACC8.17%
DTEA.CA Yearly LT Debt VS Equity VS FCFDTEA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.66 indicates that DTEA should not have too much problems paying its short term obligations.
DTEA has a better Current ratio (1.66) than 75.00% of its industry peers.
A Quick Ratio of 1.00 indicates that DTEA should not have too much problems paying its short term obligations.
DTEA's Quick ratio of 1.00 is fine compared to the rest of the industry. DTEA outperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1
DTEA.CA Yearly Current Assets VS Current LiabilitesDTEA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

DTEA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.83%, which is quite impressive.
DTEA shows a small growth in Revenue. In the last year, the Revenue has grown by 1.91%.
DTEA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.65% yearly.
EPS 1Y (TTM)76.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%164.38%
Revenue 1Y (TTM)1.91%
Revenue growth 3Y-15.95%
Revenue growth 5Y-20.65%
Sales Q2Q%2.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DTEA.CA Yearly Revenue VS EstimatesDTEA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
DTEA.CA Yearly EPS VS EstimatesDTEA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 0 0.1 -0.1 0.2 0.3

1

4. Valuation

4.1 Price/Earnings Ratio

DTEA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DTEA.CA Price Earnings VS Forward Price EarningsDTEA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, DTEA is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.7
EV/EBITDA N/A
DTEA.CA Per share dataDTEA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DTEA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DAVIDSTEA INC

TSX-V:DTEA (6/18/2025, 7:00:00 PM)

1

-0.05 (-4.76%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-28 2025-05-28/bmo
Earnings (Next)06-17 2025-06-17/bmo
Inst Owners11.22%
Inst Owner ChangeN/A
Ins Owners3.28%
Ins Owner ChangeN/A
Market Cap26.95M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.44
P/FCF 3.7
P/OCF 3.05
P/B 1.46
P/tB 1.46
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.27
FCFY27.01%
OCF(TTM)0.33
OCFY32.83%
SpS2.29
BVpS0.68
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.75%
ROE -17.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.79%
FCFM 11.78%
ROA(3y)-20.71%
ROA(5y)-6.31%
ROE(3y)-41.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.52%
GM growth 5Y-2.86%
F-Score4
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 1.88
Debt/EBITDA N/A
Cap/Depr 46.65%
Cap/Sales 2.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 1
Altman-Z -1.1
F-Score4
WACC8.17%
ROIC/WACCN/A
Cap/Depr(3y)36.98%
Cap/Depr(5y)24.87%
Cap/Sales(3y)2.08%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%164.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.91%
Revenue growth 3Y-15.95%
Revenue growth 5Y-20.65%
Sales Q2Q%2.84%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y60.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y207.55%
FCF growth 3YN/A
FCF growth 5Y-24.41%
OCF growth 1Y291.78%
OCF growth 3YN/A
OCF growth 5Y-23.2%